Clinical Trials Browser

Phase 2 × NIH × valrubicin × Clear all

NCT00003759 2013-01-31

AD 32 With or Without BCG After Surgery in Treating Patients With Newly Diagnosed or Recurrent Superficial Bladder Cancer

Phase 2 Completed

Urinary Bladder Neoplasms